Antihypertensive therapy and progression of chronic renal disease
β Scribed by Lance D. Dworkin; Douglas G. Shemin
- Book ID
- 107541974
- Publisher
- Springer
- Year
- 1999
- Tongue
- English
- Weight
- 287 KB
- Volume
- 1
- Category
- Article
- ISSN
- 1522-6417
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Antihypertensive therapy influences kidney function by different mechanisms depending on the mode of action of the drug used. The GFR is improved by calcium entry blockers and ACE inhibitors, unaffected by vasodilators, alpha-blockers and centrally acting sympatholytics and impaired by beta-blockers
## Background: Findings that early changes in proteinuria independently predict long-term glomular filtration rate (gfr) decline (delta gfr) would highlight proteinuria as a major determinant of progression in chronic renal disease. ## Methods: We investigated whether percent changes (3 months vs
## Abstract Thanks to the administration of hypocholesterolemic drugs, important advances have been made in the treatment of patients with progressive renal disease. __In vitro__ and __in vivo__ findings demonstrate that statins, the inhibitors of HMGβCoA reductase, can provide protection against k